Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia

Cardiovascular Research

Volumn 92, Issue 3, 2011, Pages 394-400

  Kudej, Raymond K ^a,b   Fasano, Mathew ^c   Zhao, Xin ^a   Lopaschuk, Gary D ^d   Fischer, Susan K ^c   Vatner, Dorothy E ^a   Vatner, Stephen F ^a   Lewandowski, E Douglas ^c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Oxidation; Coronary stenosis; Ischaemic preconditioning; Long chain fatty acids; Mitochondria

Indexed keywords

PALMITIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; GLYCOLYSIS; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE REPERFUSION; HEART PERFUSION; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PRIORITY JOURNAL; SECOND WINDOW OF PRECONDITIONING;

ACETYL COENZYME A; ANIMALS; CORONARY CIRCULATION; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLYCOLYSIS; HEMODYNAMICS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALONYL COENZYME A; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; MYOCARDIUM; OXIDATION-REDUCTION; PALMITIC ACID; RECOVERY OF FUNCTION; SUS SCROFA; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 81055133115     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr215     Document Type: Article

References (51)

1. Lewandowski ED. Metabolic mechanisms associated with antianginal therapy. Circ Res 2000;86:487-489. (Pubitemid 30165036)
2. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010;90:207-258.
3. Ussher JR, Lopaschuk GD. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion. Basic Res Cardiol 2009;104:203-210.
4. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86:580-588. (Pubitemid 30165050)
5. Higgins AJ, Morville M, Burges RA, Gardiner DG, Page MG, Blackburn KJ. Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart. Life Sci 1980;27:963-970. (Pubitemid 11254923)
6. Lopaschuk GD, Wall SR, Olley PM, Davies NJ. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res 1988;63:1036-1043. (Pubitemid 19004258)
7. Kudej RK, White LT, Kudej AB, Vatner SF, Lewandowski ED. Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs. Circulation 2002;106:2836-2841.
8. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 2002;39:718-725. (Pubitemid 34158171)
9. Racey-Burns LA, Burns AH, Summer WR, Shepherd RE. The effect of dichloroacetate on the isolated no flow arrested rat heart. Life Sci 1989;44:2015-2023. (Pubitemid 19156087)
10. McVeigh JJ, Lopaschuk GD. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol 1990;259:H1079-H1085. (Pubitemid 20352306)
11. Lewandowski ED, White LT. Pyruvate dehydrogenase influences postischemic heart function. Circulation 1995;91:2071-2079.
12. Griffin JL, White LT, Lewandowski ED. Substrate-dependent proton load and recovery of stunned hearts during pyruvate dehydrogenase stimulation. Am J Physiol Heart Circ Physiol 2000;279:H361-H367. (Pubitemid 30616679)
13. Kantor PF, Dyck JR, Lopaschuk GD. Fatty acid oxidation in the reperfused ischemic heart. Am J Med Sci 1999;318:3-14. (Pubitemid 30387269)
14. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913-931. (Pubitemid 20126423)
15. Miyamae M, Fujiwara H, Kida M, Yokota R, Tanaka M, Katsuragawa M et al. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts. Circulation 1993;88:223-234. (Pubitemid 23195453)
16. Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol 1995; 269:H1767-H1775. (Pubitemid 3005974)
17. de Albuquerque CP, Gerstenblith G, Weiss RG. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res 1994;74:139-150.
18. Simkhovich BZ, Hale SL, Kloner RA. Effect of ischemic preconditioning on carnitinelinked metabolism in the rabbit heart. Coron Artery Dis 1992;3:141-147.
19. Yoshiyama M, Merkle H, Garwood M, From AH, Bache RJ, Ugurbil K et al. Transmural distribution of 2-deoxyglucose uptake in normal and post-ischemic canine myocardium. NMR Biomed 1995;8:9-18.
20. Tong H, Chen W, London RE, Murphy E, Steenbergen C. Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase. J Biol Chem 2000;275:11981-11986. (Pubitemid 30237770)
21. Nishino Y, Miura T, Miki T, Sakamoto J, Nakamura Y, Ikeda Y et al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res 2004;61:610-619. (Pubitemid 38210166)
22. Lewandowski ED, Kudej RK, White LT, O'Donnell JM, Vatner SF. Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction. Circulation 2002;105:367-372. (Pubitemid 34106187)
23. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981;23:321-336.
24. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997;33:243-257. (Pubitemid 27072627)
25. McNulty PH, Sinusas AJ, Shi CQ, Dione D, Young LH, Cline GC et al. Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia. J Clin Invest 1996;98:62-69. (Pubitemid 26243821)
26. Vatner SF, Braunwald E. Cardiovascular control mechanisms in the conscious state. N Engl J Med 1975;293:970-976.
27. Bolli R, Li QH, Tang XL, Guo Y, Xuan YT, Rokosh G et al. The late phase of preconditioning and its natural clinical application-gene therapy. Heart Fail Rev 2007;12: 189-199. (Pubitemid 350176692)
28. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136. (Pubitemid 17174962)
29. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 h after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-1272. (Pubitemid 23264047)
30. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993;72: 1293-1299. (Pubitemid 23147612)
31. Sun JZ, Tang XL, Knowlton AA, Park SW, Qiu Y, Bolli R. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest 1995; 95:388-403.
32. Kudej RK, Kim SJ, Shen YT, Jackson JB, Kudej AB, Yang GP et al. Nitric oxide, an important regulator of perfusion-contraction matching in conscious pigs. Am J Physiol Heart Circ Physiol 2000;279:H451-H456. (Pubitemid 30616688)
33. Kudej RK, Ghaleh B, Sato N, Shen YT, Bishop SP, Vatner SF. Ineffective perfusion-contraction matching in conscious, chronically instrumented pigs with an extended period of coronary stenosis. Circ Res 1998;82:1199-1205. (Pubitemid 28311127)
34. Gwirtz PA. Construction and evaluation of a coronary catheter for chronic implantation in dogs. J Appl Physiol 1986;60:720-726.
35. Robitaille PM, Rath DP, Abduljalil AM, O'Donnell JM, Jiang Z, Zhang H et al. Dynamic 13C NMR analysis of oxidative metabolism in the in vivo canine myocardium. J Biol Chem 1993;268:26296-26301.
36. Lewandowski ED. Nuclear magnetic resonance evaluation of metabolic and respiratory support of work load in intact rabbit hearts. Circ Res 1992;70:576-582.
37. Damico LA, White LT, Yu X, Lewandowski ED. Chemical vs. isotopic equilibrium and the metabolic fate of glycolytic end products in the heart. J Mol Cell Cardiol 1996;28: 989-999. (Pubitemid 26169305)
38. O'Donnell SR, Wanstall JC. The classification of beta-adrenoceptors in isolated ring preparations of canine coronary arteries. Br J Pharmacol 1984;81:637-644. (Pubitemid 14148372)
39. Malloy CR, Thompson JR, Jeffrey FM, Sherry AD. Contribution of exogenous substrates to acetyl coenzyme A: measurement by 13C NMR under non-steady-state conditions. Biochemistry 1990;29:6756-6761. (Pubitemid 20225473)
40. Lewandowski ED, Doumen C, White LT, LaNoue KF, Damico LA, Yu X. Multiplet structure of 13C NMR signal from glutamate and direct detection of tricarboxylic acid (TCA) cycle intermediates. Magn Reson Med 1996;35:149-154.
41. Stanley WC, Hernandez LA, Spires D, Bringas J, Wallace S, McCormack JG. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. J Mol Cell Cardiol 1996;28:905-914. (Pubitemid 26169300)
42. Corkey BE. Analysis of acyl-coenzyme A esters in biological samples. Methods Enzymol 1988;166:55-70. (Pubitemid 19050732)
43. Kudej RK, Shen YT, Peppas AP, Huang CH, Chen W, Yan L et al. Obligatory role of cardiac nerves and alpha1-adrenergic receptors for the second window of ischemic preconditioning in conscious pigs. Circ Res 2006;99:1270-1276. (Pubitemid 44808664)
44. Path G, Robitaille PM, Merkle H, Tristani M, Zhang J, Garwood M et al. Correlation between transmural high energy phosphate levels and myocardial blood flow in the presence of graded coronary stenosis. Circ Res 1990;67:660-673. (Pubitemid 20314993)
45. Ugurbil K, Merkle H, Robitaille PM, Hendrich K, Yoshiyama M, Path G et al. Metabolic consequences of coronary stenosis. Transmurally heterogeneous myocardial ischemia studied by spatially localized 31P NMR spectroscopy. NMR Biomed 1989;2:317-328.
46. Zhang J, Ishibashi Y, Zhang Y, Eijgelshoven MH, Duncker DJ, Merkle H et al. Myocardial bioenergetics during acute hibernation. Am J Physiol 1997;273:H1452-H1463.
47. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997;244:1-14. (Pubitemid 27079689)
48. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 1993;268:25836-25845. (Pubitemid 23358202)
49. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 1995;270:17513-17520.
50. Dyck JR, Lopaschuk GD. Malonyl CoA control of fatty acid oxidation in the ischemic heart. J Mol Cell Cardiol 2002;34:1099-1109. (Pubitemid 35205154)
51. Zhou L, Huang H, Yuan CL, Keung W, Lopaschuk GD, Stanley WC. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation. Am J Physiol Heart Circ Physiol 2008;294: H954-H960. (Pubitemid 351253308)